Sort
51,593 grants matching “hepatitis”
Immunity and Virus Disease
$396,703Raymond M Welsh · Univ Of Massachusetts Med Sch Worcester · R37 · FY2006 · AI
Hepatic Drug Transporters in Drug Disposition
$396,653Vanderbilt University · R01 · FY2004 · GM
Reaching the hardest of the hard-to-reach
$396,652Sunil Suhas Solomon · Johns Hopkins University · DP2 · FY2023 · DA
PPHF 2012 Viral Hepatitis, Early Identification, and Linkage to Care for Persons
$396,627Alia Al-Tayyib · Denver Health And Hospital Authority · U51 · FY2012 · PS
Roles of hypothalamic JMJD3 in the regulation of leptin sensitivity and energy homeostasis
$396,615Min Hyun Kim · Arizona State University-Tempe Campus · R01 · FY2025 · DK
B-lactam mediated SOS response and expression of resistance in clinical MRSA
$396,610Adriana E Rosato · Methodist Hospital Research Institute · R01 · FY2014 · AI
Hepatic Tissue Engineering
$396,604Massachusetts General Hospital · R01 · FY2005 · DK
Reducing Vertical Transmission of Hepatitis B in Africa (REVERT-B Trial)
$396,599Jodie Ann Dionne · University Of Alabama At Birmingham · R01 · FY2023 · HD
HCV NS3 and NS5A: Biochemical Mechanisms and Biological Functions
$396,583Kevin D Raney · Univ Of Arkansas For Med Scis · R56 · FY2008 · AI
Functional Hierarchy of Remnant Lipoprotein Receptors
$396,550Sergio Fazio · Oregon Health & Science University · R01 · FY2016 · HL
Role of chitinase-3-like-1 (Chi3l1) in acetaminophen-induced liver injury
$396,542Cynthia Ju · University Of Texas Hlth Sci Ctr Houston · R01 · FY2021 · DK
Regulation of Cholesterol Catabolism by Bile Acids
$396,500Jongsook Kim Kemper · University Of Illinois At Urbana-Champaign · R01 · FY2021 · DK
Regulation of Cholesterol Catabolism by Bile Acids
$396,500Jongsook Kim Kemper · University Of Illinois At Urbana-Champaign · R01 · FY2020 · DK
Regulation of Cholesterol Catabolism by Bile Acids
$396,500Jongsook Kim Kemper · University Of Illinois At Urbana-Champaign · R01 · FY2019 · DK
HIV Vaccine Trials in Women
$396,473New York Blood Center · R01 · FY2003 · DA
Aptamer mediated targeting of Fanconi Anemia oral cancer initiating cells
$396,465Nadarajah Vigneswaran · University Of Texas Hlth Sci Ctr Houston · R01 · FY2014 · DE
Hepatic Nicotinamide N-Methyltransferase (NNMT) as a Pathogenetic Mechanism and Therapeutic Target for Alcoholic Liver Disease
$396,461Zhenyuan Song · University Of Illinois At Chicago · R01 · FY2023 · AA
Avoiding toxicity associated with MTP ablation
$396,458M Mahmood Hussain · Suny Downstate Medical Center · R01 · FY2010 · HL
Role of Adipose in Ethanol-Induced Tissue Injury
$396,436Laura E. Nagy · Cleveland Clinic Lerner Com-Cwru · R37 · FY2012 · AA
Regulation of Hepatic Heme Metabolism
$396,422Herbert L Bonkovsky · Carolinas Medical Center · R01 · FY2007 · DK
3/3 Alcohol Research Consortium in HIV â Intervention Research Arm (ARCH-IRA)
$396,390Karen L Cropsey · University Of Alabama At Birmingham · U01 · FY2016 · AA
Harvard Hepatitis B Consortium
$396,375Daryl T Lau · Beth Israel Deaconess Medical Center · U01 · FY2018 · DK
Control of stellate cells-driven liver cancer by the p62/NBR1 adapters
$396,371Jorge Moscat · Weill Medical Coll Of Cornell Univ · R01 · FY2020 · DK
HCV NS4B: Translating molecular virology into novel antiviral therapies
$396,363Jeffrey S Glenn · Stanford University · R01 · FY2014 · AI
HCV NS4B: Translating molecular virology into novel antiviral therapies
$396,363Jeffrey S Glenn · Stanford University · R01 · FY2012 · AI